Literature DB >> 18403793

Plasma homocysteine levels & 677C-->T methylenetetrahydrofolate reductase gene polymorphism in patients with coronary artery disease of different severity.

F Rassoul1, V Richter, B Hentschel, J Geisel, W Herrmann, T Kuntze.   

Abstract

BACKGROUND &
OBJECTIVE: Numerous studies have identified hyperhomocysteinemia as an independent risk factor for coronary artery disease (CAD). Furthermore, influences of polymorphysim of methylenetetrahydrofolate reductase (MTHFR) on homocysteine levels are documented. However, the relationship between severity of CAD and polymorphism of MTHFR has not been systematically evaluated. The present study was undertaken to evaluate this relationship in patients undergoing coronary artery bypass surgery.
METHODS: Serum homocysteine and MTHFR polymorphism in relation to severity of CAD was examined in 113 male patients, who all underwent coronary artery bypass surgery. The prevalences of 677 C-->T transition of the MTHFR gene were determined in these patients. Two groups were compared according to GENSINI coronary score : mild atherosclerosis (CAD stenosis < 30) and severe atherosclerosis (CAD stenosis > 30).
RESULTS: Patients with CAD showed a significantly higher serum concentration of homocysteine than control subjects (P < 0.01). The serum homocysteine level was significantly higher in patients with increased scores than in patients with mild CAD (Gensini score < 30) both with and without the MTHFR polymorphism. INTERPRETATION &amp;
CONCLUSION: The findings of our study showed that hyperhomocysteinemia was significantly related to the severity of CAD independent on MTHFR polymorphism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18403793

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  5 in total

Review 1.  Genetics of homocysteine metabolism and associated disorders.

Authors:  S Brustolin; R Giugliani; T M Félix
Journal:  Braz J Med Biol Res       Date:  2009-12-04       Impact factor: 2.590

2.  Methylenetetrahydrofolate reductase gene polymorphism in diabetes and obesity.

Authors:  Javad Tavakkoly Bazzaz; Mahnaz Shojapoor; Habibollah Nazem; Parvin Amiri; Hossein Fakhrzadeh; Ramin Heshmat; Maryam Parvizi; Shirin Hasani Ranjbar; Mahsa M Amoli
Journal:  Mol Biol Rep       Date:  2009-05-13       Impact factor: 2.316

3.  Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians.

Authors:  Santosh Kumar Gupta; Jyoti Kotwal; Atul Kotwal; Anil Dhall; Salil Garg
Journal:  Indian J Med Res       Date:  2012-04       Impact factor: 2.375

4.  Association of homocysteine and methylene tetrahydrofolate reductase (MTHFR C677T) gene polymorphism with coronary artery disease (CAD) in the population of North India.

Authors:  Rajneesh Tripathi; Satyendra Tewari; Prabhat Kumar Singh; Sarita Agarwal
Journal:  Genet Mol Biol       Date:  2010-06-01       Impact factor: 1.771

5.  Association of the methylene-tetrahydrofolate reductase gene rs1801133 C677T variant with serum homocysteine levels, and the severity of coronary artery disease.

Authors:  Nadia Bouzidi; Majed Hassine; Hajer Fodha; Mejdi Ben Messaoud; Faouzi Maatouk; Habib Gamra; Salima Ferchichi
Journal:  Sci Rep       Date:  2020-06-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.